FOXO4-DRI
Senolytic D-Retro-Inverso Peptide
FOXO4-DRI (FOXO4-p53 interfering peptide) is a D-retro-inverso peptide engineered from the FOXO4 sequence to disrupt the FOXO4-p53 interaction. Subject of preclinical aging research as a senolytic agent that selectively induces apoptosis in senescent cells while sparing healthy proliferating cells. For laboratory research use only.
Competitively disrupts the FOXO4-p53 interaction within senescent cells, releasing nuclear p53 to trigger intrinsic apoptosis selectively in cells with elevated FOXO4 expression.
For Research Use Only. Sold for in vitro laboratory research. Not for human or veterinary consumption. By purchasing, you confirm you are 21+ and a qualified research professional.
D-Retro-Inverso peptide from FOXO4 transactivation domain; disrupts FOXO4-p53.
Every batch of FOXO4-DRI ships with an independently conducted Certificate of Analysis by Janoshik Analytical or Bioviridian. The COA includes HPLC-MS chromatogram, mass spec confirmation, endotoxin levels, and heavy metals screening.
Batch number is printed on the vial label and included in your order confirmation email. Look it up at pepidyn.com/coa.
